GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (OTCPK:MKGAF) » Definitions » Volatility

MKGAF (Merck KGaA) Volatility : 31.86% (As of Dec. 13, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Merck KGaA Volatility?

Volatility is a statistical measure of the dispersion of returns for a given security or market index, it shows how the price swings around its mean. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year. In most cases, the higher the volatility, the riskier the security.

As of today (2024-12-13), Merck KGaA's Volatility is 31.86%.


Competitive Comparison of Merck KGaA's Volatility

For the Drug Manufacturers - Specialty & Generic subindustry, Merck KGaA's Volatility, along with its competitors' market caps and Volatility data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck KGaA's Volatility Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck KGaA's Volatility distribution charts can be found below:

* The bar in red indicates where Merck KGaA's Volatility falls into.



Merck KGaA  (OTCPK:MKGAF) Volatility Calculation

The annualized volatility is calculated as following:

σA=σM * 12
= 1/(n-1) ∑(Ri - R')^2 * 12

Where: σM is the monthly volatility, n is the number of months in the period, Ri is the security's historical monthly returns and R' is the arithmetic mean of monthly returns.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Merck KGaA  (OTCPK:MKGAF) Volatility Explanation

Volatility is a statistical measure of the dispersion of returns for a given security or market index. It’s often measured as standard deviation or variance of historical returns over a certain period. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year.

Volatility reflects the uncertainty or risk of a security’s value. Generally speaking, a higher volatility suggests a higher risk, because it implies a wider fluctuation around average price. This means the price of the security can change dramatically in either direction within a short period. Conversely, a lower volatility means that the security's price is more steady, which suggests a lower risk.

Another measurement of relative volatility is Beta. Beta is a measure of systematic risk of a security or a portfolio in comparison to the market as a whole. Beta is usually compared to 1. A beta of greater than 1 indicates that the security's price will be more volatile than the market.


Merck KGaA Volatility Related Terms

Thank you for viewing the detailed overview of Merck KGaA's Volatility provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck KGaA Business Description

Address
Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293
Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (44% of 2023 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (38%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (17%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Merck KGaA Headlines

From GuruFocus

Merck KGaA Capital Markets Day (Virtual) Transcript

By GuruFocus Research 02-14-2024

Q1 2021 Merck KGaA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2024 Merck KGaA Earnings Call Transcript

By GuruFocus Research 08-02-2024

Q1 2024 Merck KGaA Earnings Call Transcript

By GuruFocus Research 05-16-2024

Merck KGaA at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 02-14-2024

Q2 2023 Merck KGaA Earnings Press Conference Transcript

By GuruFocus Research 02-14-2024

Q3 2021 Merck KGaA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2022 Merck KGaA Earnings Call Transcript

By GuruFocus Research 02-14-2024